Top Markets
Coin of the day
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Kedudukan dalam Saham #33637
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Harga Saham
$0.03702159
Disegerakkan terakhir: 2024-01-29
Modal Pasaran
$7.21M
Perubahan (1 hari)
-3.08%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan Antisense Therapeutics Limited (ANP)

Kategori

Sejarah pecahan saham untuk Antisense Therapeutics Limited (ANP)
Saham Antisense Therapeutics Limited (simbol: ANP) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 17, 2026.
Satu saham ANP yang dibeli sebelum Aug 17, 2026 kini bersamaan dengan 0 saham ANP.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa